Maria Forss

BICO’s €26M Nanoscribe Sale Highlights Strategic Overhaul Under Forss

BICO (STO: BICO) announced its second divestiture since Maria Forss took over as President and CEO in November 2023. Following the sale of Ginolis last year, BICO has now entered…

Big Changes at BICO: Founders Leave as Whistleblower Revelations Spark Overhaul

In a significant development at BICO (STO: BICO), founders Erik Gatenholm and Hector Martinez have decided to leave the company after eight years, marking the end of an era for…

Featured

Exclusive Interview: BICO’s New Bioprinting Era under Maria Forss Begins

In the dynamic landscape of life sciences, Maria Forss has taken the helm as the new CEO of BICO (STO: BICO), a name that emerged from bioprinting pioneer Cellink and…

Featured

BICO’s Revival: A Fresh Era with Maria Forss at the Helm

Swedish biotech company BICO (STO: BICO) has been making waves in the industry recently. Ever since Maria Forss assumed the role of CEO in November 2023, the company seems to…

Featured

BICO’s Path to Profitability is A Test for New CEO Maria Forss

Sharing two key announcements that could signal a new direction, bioscience and bioprinting firm BICO (STO: BICO) has appointed Maria Forss as its new President and CEO. As a demonstration…